BioGenerator Ventures — Full Portfolio
109 tracked investments · listed companies and verified rows first
Pairidex offers FusionMRD, a personalized digital droplet PCR (ddPCR) assay that detects and quantifies oncogenic gene fusions from a standard peripheral blood sample to monitor treatment response and minimal residual disease in gene fusion-driven blood cancers such as leukemia.
BiotechDigital HealthHealthtechMedical DevicesSt. Louis, US
Grant Challen(Co-Founder & Scientific Advisor)inAllyson Mayer(Interim COO)inAndrew Young(Founder & CSO)Paul Kortschak(CEO)in
BoardTodd Druley(Director)
Board seatCrystal Winkeler· per SEC Form D
Co-investorsiSelect Fund
Cadre Bioscience partners with innovators to develop and bring new therapeutics to clinical application through drug development.
BiotechDeep TechHealthtechMedical DevicesSt. Louis, US
Bob Karr(Executive Chairman & CEO)
Aggio provides cloud-based SaaS platforms for sales and market intelligence in the agriculture and animal health industries, including a commercial sales platform for ag companies and a diagnostics platform for labs, vaccine manufacturers, and producers.
AgTechSaaSSales TechSt. Louis, US
Saurabh Bharadwaj(Executive Officer)inDimitri Popov(Executive Officer)
Co-investorsIIMA VenturesCultivation Capital
Agragene develops Precision-Guided Sterile Insect Technology (pgSIT) marketed as KNOCKOUT™, a biocontrol product for controlling crop insect pests such as Spotted Wing Drosophila while reducing reliance on traditional insecticides.
AgTechBiotechClimate TechSan Diego, US
Bryan Witherbee(President and CEO)inTracy Ellis(Executive Officer)Clyde Shores(Executive Officer, Director)Robert Schmidt(Director)Gordon Alton(Executive Officer, Director)David Webb(Director)
Co-investorsMissouri Technology CorporationOspraie Ag Science
Agrela Ecosystems makes PheNode, a modular environmental sensor platform that collects field and controlled-environment data through a network of solar-powered wireless sensors communicating via LoRaWAN or Bluetooth.
AgTechHardwareIoT
AgXelerators provides end-to-end product development support for agricultural innovations, covering formulation development, field demonstration, product registration, and market introduction.
AgTechClimate Tech
Amplifi Vascular develops the Amplifi Vein Dilation System, a wearable external blood pump with inflow and outflow catheters that uses proprietary hemodynamic technology to enlarge veins before arteriovenous fistula (AVF) creation.
BiotechHardwareHealthtechMedical DevicesPrairie Village, US
Sean Morris(Executive Officer, Director)
BoardNathaniel Hagedorn(Director)James Schultz(Director)Steve Braun(Director)
APT Therapeutics develops therapeutics based on human apyrase to treat thrombotic and cardiovascular conditions such as heart attack, stroke, acute lung injury, and pulmonary arterial hypertension.
BiotechNaperville, US
Aptimmune develops vaccines for swine health, partnering with vaccine development and swine health consulting companies to speed product development, testing and manufacturing.
AgTechBiotechHealthtechChampaign, US
Aaron Gilbertie(CEO)Federico Zuckermann(Executive Officer, Director)
BoardRobert Easter(Director)Paul Olivo(Director)Gary Durack(Director)
Co-investorsMissouri Technology CorporationArsenalCultivation CapitalThe Yield LabIllinois VenturesThe Yield Lab Asia Pacific
Atomation builds an IoT platform that connects new and legacy devices to the internet and turns their data into monitoring insights and alerts for operations teams.
Advanced ManufacturingHardwareIoTSaint Louis, US
Guy Weitzman(Co-Founder & CPO)inSteve Hassell(CEO)Eran Keshet(Co-Founder & CTO)Yoel Cheshin(Director)
BoardReuvin Avi-Tal(Director)Christopher Dorr(Director)
Co-investors2B.VCJoule Ventures
Bacterioscan develops diagnostic technologies and solutions for bacterial detection and identification.
BiotechHealthtechMedical DevicesSt. Louis, US
Dana A. Marshall(President and Chief Executive Officer)inMichael E. Thaman, Sr.(CEO & Chairman of the Board)
BoardMichael E. Thaman(Director)Amnon Weischelbaum(Director)Richard R. Vietor(Director)James Brigham, Jr.(Director)
Confluence Genetics (operating at bensonhillbio.com) is a seed innovation company that develops soybean genetics using AI-driven plant science and proprietary tools such as eMERGE Genetics and CropOS.
Durham, US
Matthew B Crisp(Executive Officer, Director)Lee Palles(Executive Officer)inNadine Carozzi(Executive Officer)Todd C Mockler(Executive Officer)Thomas Brutnell(Executive Officer)
BoardDaniel J Broderick(Director)
Co-investorsActivant CapitalAlexandriaCultivation CapitalFall Line CapitalGV (Google Ventures)iSelect Fund+7 more
Benson Hill develops soybean seed varieties using plant genetics and AI-driven plant science to produce more nutritious and energy-dense soy for agriculture and food markets.
AgTechAI & Machine LearningFoodTech
Matthew Crisp(Founder)
Co-investorsActivant CapitalGV (Google Ventures)iSelect FundLewis & Clark VenturesManta Ray VenturesMercury Fund+4 more
BIOIO develops a genetics-based platform for elucidating drug mechanisms of action, combining decades of research in pharmacology with big data and automation to accelerate drug discovery and development.
AI & Machine LearningBiotechDeep TechLongevity
Dr. Peterson
Co-investorsLifespan Vision VenturesMissouri Technology CorporationquadraScope Venture Fund
Bond Biosciences is a clinical-stage biopharmaceutical company developing non-absorbed oral therapeutics that bind excess ions in the gastrointestinal tract to treat ion-related diseases.
BiotechHealthtechParkville, US
Michael A. Riley(Executive Officer, Director)Cory Berkland(Executive Officer, Director)
BoardMichael Beckloff(Director)Timothy Opler(Director)
Buck Surgical develops surgical technologies aimed at improving outcomes for complex procedures and expanding patient access to reconstructive and limb-preserving treatments.
HardwareHealthtechMedical DevicesSt. Louis, US
Donald W. Buck II(Founder)inDonald Buck(Executive Officer, Director)
Co-investorsCentennial InvestorsMissouri Technology Corporation
C2N Diagnostics develops and commercializes blood-based diagnostic tests for Alzheimer's disease and other neurodegenerative conditions, using proprietary LC-MS/MS mass spectrometry to detect brain amyloid pathology.
BiotechDigital HealthMedical DevicesSt. Louis, US
Dr. David Holtzman(Director)Dr. Randall Bateman(Director)Dr. Joel Braunstein(Executive Officer, Director)Micah Onixt(Executive Officer)
BoardDr. Michael Goldblatt(Director)
Cadex Genomics develops blood-based diagnostic assays for cancer patients.
BiotechDigital HealthHealthtech
Caeli Vascular develops a medical device platform for the treatment of venous thrombotic disease, specifically designed to remove blood clots in deep vein thrombosis cases.
HealthtechMedical DevicesSt. Louis, US
Co-investorsMissouri Technology Corporation
Canopy Biosciences (Bruker Spatial Biology) develops spatial biology instruments and assays for analyzing gene expression, RNA, and proteins in tissue samples.
BiotechHealthtechMedical DevicesSaint Louis, US
EDWARD WEINSTEIN(President, Chief Executive Officer and Manager)inCRYSTAL WINKELER(Chief Operating Officer)CHARLES BOLTEN(Director)DAVID KINGSLEY(Director)
BoardDAVID SMOLLER(Director)in
Co-investorsAmpersand
CapyBio provides tools to measure how closely cells match a target identity and to improve them, helping scientists and biopharma teams reduce failure in drug discovery, build stronger disease models, and advance cell-based therapies.
AI & Machine LearningBiotechDeep TechHealthtech
Guillermo Rivera(Interim CEO, Co-Founder & CSO)inSamantha Morris(Co-Founder)Kunal Jindal(Co-Founder & CTO)in
Co-investorsMissouri Technology CorporationCultivation Capital
Cofactor Genomics develops predictive diagnostics for cancer immunotherapy using RNA-expression models to characterize tumor microenvironments and predict patient response.
AI & Machine LearningBiotechHealthtechMedical DevicesSt. Louis, US
Dave Messina(COO)inJarret Glasscock(CTO)inJarret Glassock(Executive Officer, Director)Jon Armstrong(COO)inJonathan Wald(Software Engineering Intern)
BoardMatthew A. Ocko(Director)in
Co-investorsArgonautic VenturesAscension VenturesDCVC (Data Collective)Fifty YearsiSelect FundJude Gomila+11 more
Confluence Discovery Technologies is a full-service drug discovery contract research organization (CRO) that partners with pharma and biotech companies across cell and molecular biology, biochemistry, enzymology, immunology, in vivo efficacy, and medicinal chemistry.
BiotechDeep Tech
Cortex is an innovation district in St.
Impact & Social GoodSt. Louis, US
CoverCress Inc. develops agricultural products and seeds that enable farmers to convert idle winter fields into profitable crops.
AgTechCleantechClimate TechEnergyOlivette, US
Jim Hedges(CEO)in
Co-investorsFulcrum Global CapitalPrelude VenturesProlog VenturesCultivation Capital
Daya CNS is a pharmaceutical company focused on drug discovery and development for central nervous system disorders, with expertise in small molecule therapeutics targeting pain and related conditions.
BiotechHealthtechMedical DevicesSaint Louis, US
Raj Devraj(Director)Walter Smith(Director)Steve Hanley(Chairman of the Board)Ragahavan Rajagopalan(Executive Officer, Director)Raghavan Rajagopalan(Chief Scientific Officer)Jeffrey Boone(General Counsel)
Edison Agro Sciences develops bio-based synthetic rubber from sunflower crops as an alternative to petrochemical and natural rubber for industrial applications.
AgTechBiotechCleantechNew MaterialsSt. Louis, US
David Woodburn(Executive Officer, Director)inMatthew B Crisp(Executive Officer, Director)Thomas Hohn(Executive Officer, Director)inTom Christensen(Executive Officer, Director, Promoter)
BoardDan Broderick(Director)Matt Helms(Director)
Co-investorsArieal Southeast Angel Partners
Electrochaea is a Power-to-Gas technology company whose patented biomethanation process uses a proprietary strain of archaea to convert CO2 and green hydrogen into grid-quality renewable e-methane.
BiotechCleantechDeep TechEnergy
Laurens Mets(Founder / Scientific originator)in
Co-investorsMatterwave VenturesMissouri Technology CorporationMunich Venture PartnersEuropean Innovation Council Fund
Equator Therapeutics develops first-in-class drugs targeting mitochondrial thermogenesis to treat obesity and metabolic disorders by restoring the body's natural heat production mechanism.
BiotechHealthtechSan Francisco, US
Liliya Khasin(Founder)inYuriy Kirichok(Founder)inJonah Sinick(Founder)in
Co-investorsEndurance28Evolution VC PartnersSand Hill AngelsSV Latam CapitalY Combinator
Euclises Pharmaceuticals develops oral, small-molecule drugs targeting COX-2 to disrupt the tumor microenvironment and enhance cancer cell death, particularly when combined with immune checkpoint inhibitors or EGFR inhibitors.
BiotechHealthtechMedical Devices
Co-investorsArgonautic VenturesiSelect FundCultivation CapitalMissouri Technology Corporation
Euphrates Vascular develops the Pulse NanoMED System, a nanoscale interventional medical device that uses magnetically guided iron-oxide nanoparticles to reach and disrupt distal vascular occlusions beyond the reach of wires and catheters.
BiotechHealthtechMedical DevicesSt. Louis, US
Troy Long(Executive Officer)Jeffrey Blair(Director)Tim Blair(Executive Officer)inEric Moessinger(Director)Robert Mitchell(Director)Thomas Hillman(Director)
Co-investorsAnthro VenturesMissouri Technology CorporationOSF VenturesView Ventures+ND CapitalCultivation Capital
Galera Therapeutics is a biotechnology company developing antibody-based and other therapeutics.
BiotechHealthtechMedical DevicesMalvern, US
Mel Sorensen(Executive Officer, Director)inJoel Sussman(Executive Officer)inJeffery L. Keene(Executive Officer)inDennis P. Riley(Executive Officer)inJon T. Holmlund(Executive Officer)Robert A. Beardsley(Executive Officer, Director)in
Co-investorsNew Enterprise Associates (NEA)Sofinnova Ventures
Geneoscopy develops innovative diagnostic technologies for gastrointestinal health, specifically focused on the detection of colorectal cancer.
BiotechDigital HealthHealthtechMedical DevicesSt. Louis, US
Andrew Barnell(Chief Executive Officer & Co-founder)inErica Barnell(Co-founder)in
Co-investorsDorm RoomiSelect FundMissouri Technology CorporationCultivation Capital
Graematter is a regulatory intelligence firm that analyzes FDA and medical device regulatory data, offering its SOFIE platform to turn regulatory information into strategic insights.
AI & Machine LearningHealthtechMedical Devices
Immunophotonics is a clinical-stage biotech company developing novel treatments for solid-tumor cancers and infectious diseases by combining tumor ablation with systemic cancer immunotherapy.
BiotechDeep TechDigital HealthMedical DevicesSt. Louis, US
Dr. Hode(Co-Founder & Senior Fellow)Mr. Alleruzzo(Co-Founder & Director)Dr. Chen(Co-Founder)Dr. Robert Nordquist(Co-Founder)Luciano Alleruzzo(Director, Promoter)Wei Chen(Director, Promoter)
Co-investorsArgonautic VenturesCentennial InvestorsiSelect FundMissouri Technology CorporationCultivation Capital
Impetus Ag develops early- to late-stage agricultural technologies, with a focus on Bt discovery and development and insecticidal proteins for insect and pest control in crops.
AgTechBiotechDeep TechSt. Louis, US
Jeffrey Staub(Co-founder & former Chief Scientist)inMartha Schlicher(CEO, Board of Directors)inBrian McNulty(Dr. Brian McNulty became CTO on 1/1/2021)Alexander Hromockyj(CTO)inThomas Malvar(COO)inMartha Schlicher, Ph.D., MBA(CEO, Board of Directors)
Co-investorsCentennial InvestorsMissouri Technology CorporationRadicle GrowthSwan Venture FundCultivation CapitalTet Ventures
INTENT brings together agronomic expertise and commercial knowledge across the agricultural value chain to serve clients in the sector.
AgTechB2B MarketplacesSaaS
Co-investorsOspraie Ag ScienceHaatchPortfolio VenturesPXN Ventures
Intershunt develops the Dynama System (also known as the PAS-C System), an investigational interatrial shunting device designed to create a pathway in the heart's upper chambers to reduce elevated left atrial pressure and relieve heart failure symptoms.
HardwareHealthtechMedical DevicesFridley, US
Harlan Lee Sorkin(Executive Officer, Director)Gil M. Vardi(Director)
BoardDenis Harrington(Director)inDavid Adair(Director)inJim Bullock(Director)
Co-investorsSolas BioVentures
KaloCyte develops ErythroMer, a dried, shelf-stable artificial red blood cell for use in emergency and trauma care when stored blood is unavailable or in short supply.
BiotechDeep TechHealthtechMedical DevicesBaltimore, US
Allan Doctor(Co-Founder & CSO)inDipanjan Pan(Co-Founder, Chief Technical Officer)inPhilip Spinella(Co-Founder, Chief Medical Officer)inDaniel Getman(Director)Gregory Lanza(Director)
Co-investorsBioAdvanceDelaware Crossing Investor GroupMaryland TEDCONYBC VenturesOld Line Capital PartnersTEDCO+1 more
Katalyst Surgical manufactures ophthalmic microsurgical instruments, including reusable handles and disposable forceps and scissors tips available in 23ga, 25ga, and 27ga sizes.
Medical Devices
Kinimmune develops localized immunotherapies that activate the immune system at the site of solid tumors.
BiotechHealthtech
Kogent Surgical is a medical device manufacturer that designs and produces microsurgical instrumentation, including disposable and reusable non-stick bipolar forceps, lighted suctions, scissors, and titanium micro-surgery instruments.
Advanced ManufacturingHealthtechMedical DevicesChesterfield, US
Gregg Scheller(Founder)inWilliam L Bates(Executive Officer, Promoter)
Kypha develops clinical diagnostic tests for immune system biomarkers, particularly complement activity markers, and provides solutions for real-time immune insights across therapeutic areas.
BiotechDeep TechHealthtechMedical DevicesSt. Louis, US
Nick Staten(Executive Officer)inT. Scott Glover(Executive Officer)inPaul K. Olson(Executive Officer, Director)
BoardDavid Smoller(Director)inJames D. Marselis(Director)Peter Reinecke(Director)in
Co-investorsMissouri Technology CorporationArsenalSerra Ventures
Lingrove designs and manufactures Ekoa, a bio-based composite material made from flax and plant resins used as wall protection, wall coverings, ceilings, and millwork for hospitality, healthcare, and workplace interiors, as well as automotive interior applications.
CleantechConstruction TechNew MaterialsSan Rafael, US
Joseph Luttwak(Executive Officer, Director)in
BoardTalley Goodson(Director)Thomas Crow(Director)Stephen P. Welker(Director)
Co-investorsBoro CapitalCool Climate CollectiveDiamond Edge VenturesGaingelsSeaX VenturesSOSV+5 more
MediBeacon develops biocompatible fluorescent tracer agents detected by skin sensors for clinical diagnostic applications including kidney function assessment and gastrointestinal permeability measurement.
AI & Machine LearningBiotechHealthtechMedical DevicesSaint Louis, US
Richard Dorshow(Executive Officer, Director)inTerence Stern(Executive Officer)inSteven Hanley(Executive Officer, Director)
BoardSteven Miller(Director)David Present(Director)Cherine Plumaker(Director)
Co-investorsMissouri Technology CorporationNewlin Investment Company LLC
Mobius Therapeutics makes Mitosol, an FDA-indicated mitomycin kit used topically as an adjunct to ab externo glaucoma filtration surgery.
BiotechMedical Devices
Co-investorsCultivation Capital
Neurolutions makes IpsiHand, an FDA-cleared brain-computer interface system for at-home motor rehabilitation of chronic stroke survivors with arm and hand weakness.
BiotechDigital HealthHealthtechMedical DevicesVan Nuys, US
Eric Leuthardt(Director)inLeo Petrossian(Executive Officer, Director)in
BoardYuanwei Tai(Director)Kevin Reilly(Director)inFred Khosravi(Director)inStavros Vizirgianakis(Director)
Co-investorsExcelestar VenturesAlly Bridge GroupAmed Ventures
Norfolk Healthy Produce sells seeds for the bioengineered Purple Tomato, developed to contain higher antioxidant levels, and offers them to home growers through an online seed store.
AgTechBiotechFoodTech
Omniose develops a platform for bioconjugate vaccine development using glycoconjugation technology to create vaccines against bacterial pathogens like Group B Streptococcus and Klebsiella pneumoniae.
BiotechDeep TechHealthtechMedical DevicesSt. Louis, US
Dr. Harding(Primary Founder)Mario Feldman(Founder, Scientific Founder)Viliam PavliakBenjamin Moutierin
BoardDr. SzymanskiDr. Projan
Panome Bio provides metabolomics, proteomics, and multi-omics integration workflows along with a computational platform that analyzes and integrates diverse biological data types.
AI & Machine LearningBiotechDeep TechHealthtechSaint Louis, US
Edward Weinstein(Executive Officer, Director)inTom Cohen(Executive Officer)in
BoardDavid Smoller(Director)inDeval Lashkari(Director)inAlexander Herzick(Director)inRob Capone(Director)in
Co-investorsTelegraph Hill PartnersCultivation Capital
Plastomics develops trait delivery technology for agriculture using cell biology, plant tissue culture, transformation, and molecular biology methods.
AgTechBiotechSt. Louis, US
Jeffrey Staub(Executive Officer, Director)inElizabeth Gallegos(Executive Officer)in
BoardMartha Schlicher(Executive Officer, Director)inBrian Clevinger(Director)Charles Bolten(Director)Dave Duncan(Director)
Co-investorsArgonautic VenturesCentennial InvestorsFulcrum Global CapitaliSelect FundMissouri Technology CorporationRevolution+2 more
RevivBio uses protein engineering and advanced microfluidics to develop biotechnology products.
BiotechDeep TechFrederick, US
Fatemeh Aileen Mastouri(Executive Officer, Director)
Co-investorsAlumni VenturesSeventure Partners
RNAiSSANCE AG develops RNAi-based solutions for agricultural pest control, using biomanufacturing, strain development, and entomology research.
AgTechBiotechClimate TechSt. Louis, US
Steve Meyer(Chief Executive Officer)inBrad Fabbri(Director)Michael Helmstetter(Executive Officer, Director)Brett Morris(Director)Harold W. Davies(Director)
Co-investorsMissouri Technology CorporationCultivation Capital
Saluna develops industrial hemp seeds bred to keep THC below 0.3%, positioning the crop as an alternative to existing row crops for oil and feed markets.
AgTechFoodTechSt. Louis, US
Matt Plummer(Executive Officer)inMatt Helms(Executive Officer, Director)
BoardRick Holton, Jr.(Director)inMike DeCamp(Director)Brian Salmo(Director)James McCarter(Director)
Co-investorsMissouri Technology CorporationFINTOP Capital
SentiAR builds CommandEP, an FDA-cleared mixed-reality holographic augmented reality platform for cardiac electrophysiology that converts real-time catheter data into hands-free 3D holograms and virtual screens for electrophysiologists during procedures.
AI & Machine LearningHealthtechMedical DevicesSt. Louis, US
Jonathan Silva(Executive Officer, Director)Berk Tas(Executive Officer, Director)inJames Patrick Howard(Executive Officer)
BoardSean Churchill(Director)Warren Watson(Director)
Co-investorsMissouri Technology CorporationHarmonix FundService Provider CapitalCultivation Capital
Solis Agrosciences is an agricultural science company with a team focused on molecular sciences, plant transformation, and plant research.
AgTechBiotechFoodTechSaint Louis, US
Susan Martino-Catt(President and COO)inCharles Bolten(Director)Mary Fernandes(Executive Officer)Tom Cohen(Executive Officer, Director)inBrian Salmo(Director)
BoardDavid Smoller(Co-Founder & Director)in
Co-investorsMissouri Technology CorporationCultivation CapitalFINTOP Capital
The Danforth Technology Company (DTC) is a subsidiary of the Donald Danforth Plant Science Center that helps commercialize plant-science technologies developed by Danforth Center scientists.
AgTechBiotechDeep Tech
StartRight makes protein-packed, gluten-free breakfast foods such as sausage and egg white sliders designed to be heated quickly for an on-the-go meal.
ConsumerFoodTech
Status Health offers at-home lab testing kits that use mass spectrometry to measure 313 chemical biomarkers from agricultural, industrial, household, and personal care sources.
Digital HealthHealthtechWellness & Fitness
SweetSpot provides a remote diabetes monitoring and management platform that improves data accessibility for clinicians and supports patients using diabetes technology such as CGMs and insulin pumps.
Digital HealthHealthtechMedical DevicesSaaS
Stephen Von Rump(Chief Executive Officer)inRalph Oiknine(Chief Medical Officer)Abigail Cohen(Chief Commercial Officer)inAmiad Fredman(Chief Product Officer)in
Co-investorsMissouri Technology CorporationCultivation Capital
Unleash Immuno Oncolytics is an immuno-oncology company developing armed, conditionally replicating oncolytic viruses that target both tumor cells and the tumor-associated stroma to trigger a systemic anti-cancer immune response.
BiotechLongevitySt. Louis, US
Ariel Muslera(Director)Ricardo Lisandro Bril(Director)Daniel Katzman(Executive Officer, Director)inBolten Charles(Director)
Valo Health applies technology and data to drug discovery, working across the technology, biotech, and healthcare fields.
AI & Machine LearningBiotechHealthtech
David Berry(Founder)in
Co-investorsAtinum Investment Co. Ltd.Flagship PioneeringHBM Healthcare InvestmentsHBM PartnersKoch Disruptive TechnologiesWestern Technology Investment
WellSky develops clinical software solutions for blood and pharmacy management, with a focus on medication management and related healthcare operations.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechImpact & Social GoodSaaSAustin, US
Bill Millerin
Co-investorsLeonard GreenTPGGE Ventures
Allotera (formerly Wugen) develops allogeneic T-cell therapies.
BiotechHealthtechMedical DevicesSt. Louis, US
Ayman Kabakibi(Executive Officer)inCherry Thomas(Executive Officer)inKumar Srinivasan(Executive Officer, Director)inKeith Vendola(Executive Officer)Daniel M Kemp(Executive Officer, Director)Matthew Cooper(Executive Officer)
Co-investorsAisling CapitalAlpha Wave GlobalRiverVest Venture PartnersAbingworthFidelity InvestmentsIntermediate Capital Group+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
@TAG BioAccuronix TherapeuticsAfernaAllotera TherapeuticsApertus PharmaceuticalsArch Oncology IncArrayBridgeAurenarAxioforceBlueStrataCareSignalConfluenceCourier TherapeuticsCurimetaDiSARM TherapeuticsFerris GenomicsForward DefenseGaleraGet HelpHalyard TherapeuticsImmune Functional Diagnostics (IFDx)Ionic TransportJourneys MetabolicLiquidCell DxLymbus OncologyMaxFiMiller BiosciencesOpenCell TechnologiesOxaluRxPeptyde BioPrecision VirologicsPrognosiaProstate Management DiagnosticsProvanAISARmontSilent SurgicalSpectrum PerceptionSyndeavor TherapeuticsSynerZTraxxssonWakyn Sleep Technologies
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.







































































































__Twitter.png)

















































